Galectin Therapeutics Inc. (GALT)

[thefamilyman]

The broader market is down. Biotech's are down. I think what we are experiencing must be just the normal inconsistency of the market.

I agree with Biotech2010's comparison to ICPT. Perhaps the small sample size of Cohort 1 may explain the market cap difference between ICPT and GALT? Maybe the "big boys" require a larger sample size before they accept the results as statistically significant?

Also, I have confidence in GALT's management team. But if you think that GALT's management would falsify data or otherwise scam investors, you should probably sell.

bradfor123 said...

If results were better than expected why is this dropping , is it possible the results were made to look better than they really were as this does look strange